SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-21-003032
Filing Date
2021-06-07
Accepted
2021-06-07 16:05:18
Documents
1
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5704
  Complete submission text file 0000902664-21-003032.txt   7585
Mailing Address 717 5TH AVENUE 16TH FL. NEW YORK NY 10022
Business Address 717 5TH AVENUE 16TH FL. NEW YORK NY 10022 212-257-4330
Slate Path Capital LP (Reporting) CIK: 0001559706 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38787 | Film No.: 21999550

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Issuer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SLATE PATH CAPITAL LP 717 FIFTH AVENUE, 16TH FLOOR NEW YORK NY 10022
Business Address
Greenspan David Gerald (Reporting) CIK: 0001820641 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38787 | Film No.: 21999549